San Diego--With follow-up for as long as 5 years, the non-frozen cadaveric transvaginal sling has provided excellent results for treatment of stress urinary incontinence with or without prolapse repair and is associated with minimal morbidity, Los Angeles investigators reported at the AUA Western Section meeting.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.